Quarterly ResultMay 6, 2026, 04:03 PM
Alpha Teknova Q1 Revenue Up 13% to $11.1M; Reaffirms 2026 Guidance
AI Summary
Alpha Teknova, Inc. announced its first quarter 2026 financial results, reporting a 13% increase in total revenue to $11.1 million. The growth was significantly driven by an 85% surge in Clinical Solutions revenue. The company also saw an improvement in gross margin to 34.2% and reduced its Adjusted EBITDA and Free Cash Outflow compared to the prior year. Teknova reaffirmed its full-year 2026 revenue guidance of $42 million to $44 million and anticipates Free Cash Outflow of less than $10 million.
Key Highlights
- Q1 2026 total revenue was $11.1 million, up 13% from $9.8 million in Q1 2025.
- Clinical Solutions revenue surged 85% to $2.1 million; Lab Essentials revenue rose 3% to $8.4 million.
- Gross profit for Q1 2026 was $3.8 million, with gross margin improving to 34.2% from 30.7% in Q1 2025.
- Net loss for Q1 2026 was $4.6 million, or $(0.08) per diluted share, compared to $(0.09) in Q1 2025.
- Adjusted EBITDA improved to $(2.0) million from $(2.5) million in Q1 2025.
- Cash used in operating activities was $3.4 million, an improvement from $4.1 million in Q1 2025.
- Company reaffirmed 2026 revenue guidance of $42 million to $44 million and Free Cash Outflow of less than $10 million.